PubMed for id: 79728

Year	Number of Results
1993	2
2002	2
2003	1
2004	4
2005	1
2006	5
2007	7
2008	10
2009	26
2010	24
2011	22
2012	14
2013	20
2014	22
2015	27
2016	22
2017	22
2018	19
2019	19
2020	20
2021	26
2022	11
2023	10
2024	2

1

PALB2-mutated human mammary cells display a broad spectrum of morphological and functional abnormalities induced by increased TGFβ signaling.

Tuppurainen H, Laurila N, Nätynki M, Eshraghi L, Tervasmäki A, Erichsen L, Sørensen CS, Pylkäs K, Winqvist R, Peltoketo H. Tuppurainen H, et al. Cell Mol Life Sci. 2024 Apr 10;81(1):173. doi: 10.1007/s00018-024-05183-6. Cell Mol Life Sci. 2024. PMID: 38597967 Free PMC article.

2

PALB2 germline mutations in a large cohort of Middle Eastern breast-ovarian cancer patients.

Siraj AK, Bu R, Parvathareddy SK, Iqbal K, Azam S, Qadri Z, Al-Rasheed M, Haqawi W, Diaz M, Victoria IG, Al-Badawi IA, Tulbah A, Al-Dayel F, Ajarim D, Al-Kuraya KS. Siraj AK, et al. Sci Rep. 2023 May 11;13(1):7666. doi: 10.1038/s41598-023-34693-9. Sci Rep. 2023. PMID: 37169825 Free PMC article.

3

Low Expression of PALB2 is Associated With Poor Survival in Chinese Women With Primary Breast Cancer.

Liu J, Chen J, Sun J, Yao L, Zhang J, Xie Y, Xu Y. Liu J, et al. Clin Breast Cancer. 2023 Jun;23(4):e259-e266. doi: 10.1016/j.clbc.2023.03.003. Epub 2023 Mar 8. Clin Breast Cancer. 2023. PMID: 36997402

4

Contribution of germline PALB2 variants to an unselected and prospectively registered pancreatic cancer patient cohort in Pakistan.

Muhammad N, Sadaqat R, Naeemi H, Masood I, Hassan U, Ijaz B, Hanif F, Syed AA, Yusuf MA, Rashid MU. Muhammad N, et al. HPB (Oxford). 2022 Dec;24(12):2134-2144. doi: 10.1016/j.hpb.2022.09.003. Epub 2022 Sep 15. HPB (Oxford). 2022. PMID: 36175305 Free article.

5

PALB2 germline mutations in a multi-gene panel testing cohort of 1905 breast-ovarian cancer patients in Argentina.

Gonzalez A, Del Greco F, Vargas-Roig L, Brun B, Tabares G, Mampel A, Montes C, Martin C, Lopez M, Rossi N, Bruno L, Ponce C, Quaglio P, Yanzi A, Acevedo S, Lugo L, Lopez Breccia P, Avila S, Sisterna S, Del Castillo MS, Vazquez M, Nuñez LM. Gonzalez A, et al. Breast Cancer Res Treat. 2022 Jul;194(2):403-412. doi: 10.1007/s10549-022-06620-5. Epub 2022 May 24. Breast Cancer Res Treat. 2022. PMID: 35610400

6

Contribution of large genomic rearrangements in PALB2 to familial breast cancer: implications for genetic testing.

Li N, Zethoven M, McInerny S, Healey E, DeSilva D, Devereux L, Scott RJ, James PA, Campbell IG. Li N, et al. J Med Genet. 2023 Feb;60(2):112-118. doi: 10.1136/jmedgenet-2021-108399. Epub 2022 Apr 8. J Med Genet. 2023. PMID: 35396271

7

Detection of a pathogenic Alu element insertion in PALB2 gene from targeted NGS diagnostic data.

Eyries M, Ariste O, Legrand G, Basset N, Guillerm E, Perrier A, Duros C, Cohen-Haguenauer O, de la Grange P, Coulet F. Eyries M, et al. Eur J Hum Genet. 2022 Oct;30(10):1187-1190. doi: 10.1038/s41431-022-01064-3. Epub 2022 Mar 11. Eur J Hum Genet. 2022. PMID: 35277653 Free PMC article.

8

Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants.

Valenzuela-Palomo A, Bueno-Martínez E, Sanoguera-Miralles L, Lorca V, Fraile-Bethencourt E, Esteban-Sánchez A, Gómez-Barrero S, Carvalho S, Allen J, García-Álvarez A, Pérez-Segura P, Dorling L, Easton DF, Devilee P, Vreeswijk MP, de la Hoya M, Velasco EA. Valenzuela-Palomo A, et al. J Pathol. 2022 Mar;256(3):321-334. doi: 10.1002/path.5839. Epub 2021 Dec 28. J Pathol. 2022. PMID: 34846068 Free PMC article.

9

PALB2 mutations and prostate cancer risk and survival.

Wokołorczyk D, Kluźniak W, Stempa K, Rusak B, Huzarski T, Gronwald J, Gliniewicz K, Kashyap A, Morawska S, Dębniak T, Jakubowska A, Szwiec M, Domagała P, Lubiński J, Narod SA, Akbari MR, Cybulski C; Polish Hereditary Prostate Cancer Consortium. Wokołorczyk D, et al. Br J Cancer. 2021 Aug;125(4):569-575. doi: 10.1038/s41416-021-01410-0. Epub 2021 May 18. Br J Cancer. 2021. PMID: 34006922 Free PMC article.

10

A Validated Functional Analysis of Partner and Localizer of BRCA2 Missense Variants for Use in Clinical Variant Interpretation.

Brnich SE, Arteaga EC, Wang Y, Tan X, Berg JS. Brnich SE, et al. J Mol Diagn. 2021 Jul;23(7):847-864. doi: 10.1016/j.jmoldx.2021.04.010. Epub 2021 May 6. J Mol Diagn. 2021. PMID: 33964450 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

281 results

Results by year